Skip to main content
2023 ACCP Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Xiling Jiang, PhD

Clinical Pharmacology Reviewer, Oncology
US Food & Drug Administration

Xiling Jiang, Ph.D. is a Master Clinical Pharmacology reviewer working in the Office of Clinical Pharmacology, Division of Cancer Pharmacology I, US Food & Drug Administration. Prior to join US FDA, Dr. Jiang worked at Janssen Research & Development, LLC, where she supported translational and clinical pharmacology of biological products, with a major focus on mechanistic PK/PD modeling of immune-oncology agents including T cell redirecting bispecific antibodies.

Dr. Jiang received B.S. degree in Medicinal Chemistry and M.S. degree in Pharmacology both from China Pharmaceutical University. She received Ph.D. degree in Pharmaceutical Sciences from University at Buffalo. She also finished post-doctoral trainings at University of Florida and US FDA, where her research included pediatric dosing and personalized medicine using quantitative approach.

Presentation(s):